Clinical significance of circulating anti-p53 antibodies in European patients with hepatocellular carcinoma. (Q36618179)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10027337%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

title

Clinical significance of circulating anti-p53 antibodies in European patients with hepatocellular carcinoma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10027337%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10027337%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

author name string

Lelong JC

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10027337%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

Azoulay D

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10027337%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

Salvucci M

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10027337%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

Reynes M

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10027337%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

Bismuth H

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10027337%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

Debuire B

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10027337%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

Lemoine A

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10027337%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

language of work or name

English

0 references

publication date

1 February 1999

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10027337%20AND%20SRC:MED&resulttype=core&format=json

British Journal of Cancer

10 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10027337%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

volume

79

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10027337%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

issue

3-4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10027337%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

page(s)

604-610

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10027337%20AND%20SRC:MED&resulttype=core&format=json

Inhibition of p53 DNA binding by human papillomavirus E6 proteins

10 November 2019

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362420

Expression and complex formation of simian virus 40 large T antigen and mouse p53 in insect cells

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362420

Immune response to p53 is dependent upon p53/HSP70 complexes in breast cancers

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362420

Anti-p53 antibodies in sera from patients with chronic obstructive pulmonary disease can predate a diagnosis of cancer.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362420

Prognostic significance of serum anti-p53 antibody in patients with hepatocellular carcinoma

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362420

Circulating antibodies against p53 protein in patients with ovarian carcinoma. Correlation with clinicopathologic features and survival.

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362420

Liver resection versus transplantation for hepatocellular carcinoma in cirrhotic patients

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362420

Anti-p53 Antibodies in Sera of Workers Occupationally Exposed to Vinyl Chloride

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362420

Prognosis of unresectable hepatocellular carcinoma: an evaluation based on multivariate analysis of 90 cases

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362420

The immune response to p53 in breast cancer patients is directed against immunodominant epitopes unrelated to the mutational hot spot

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362420

Primary treatment of hepatocellular carcinoma by arterial chemoembolization

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362420

Analysis of the p53 tumor-suppressor gene in hepatocellular carcinomas from Britain

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362420

Predictive score for the development of hepatocellular carcinoma and additional value of liver large cell dysplasia in Western patients with cirrhosis

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362420

Antibodies against p53 are associated with poor prognosis of colorectal cancer

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362420

Serum p53 antibodies in patients with oral lesions: correlation with p53/HSP70 complexes

20 September 2018

1 reference

12 December 2020

Prognostic factors in the treatment of hepatocellular carcinoma with transcatheter arterial embolization and arterial infusion

1 reference

12 December 2020

Analysis of the p53 gene in European hepatocellular carcinomas and hepatoblastomas

1 reference

12 December 2020

The humoral immune response to p53 in patients with hepatocellular carcinoma is specific for malignancy and independent of the α-fetoprotein status

1 reference

12 December 2020

Prevalence of serum antibodies against the p53 tumor suppressor gene protein in various cancers

1 reference

12 December 2020

Overexpression of p53 protein and Ki67 proliferative index in hepatocellular carcinoma: an immunohistochemical study on 109 Italian patients

1 reference

12 December 2020

Serum p53 antibodies as early markers of lung cancer

1 reference

12 December 2020

Analysis of p53 serum antibodies in patients with head and neck squamous cell carcinoma

1 reference

12 December 2020

The role of anti-p53-autoantibodies in pancreatic disorders

1 reference

12 December 2020

Characterisation and clinicopathological correlates of serum anti-p53 antibodies in breast and colon cancer

1 reference

12 December 2020

Anti-p53 antibodies in serum of smokers and head and neck cancer patients

1 reference

12 December 2020

Circulating antibodies against p53 protein in patients with ovarian carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6690095

7 January 2021

p53 protein accumulation in European hepatocellular carcinoma is not always dependent on p53 gene mutation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6690095

7 January 2021

Characterization of baculovirus recombinant wild-type p53. Dimerization of p53 is required for high-affinity DNA binding and cysteine oxidation inhibits p53 DNA binding

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6690095

7 January 2021

Massively parallel sequencing analysis of 68 gastric-type cervical adenocarcinomas reveals mutations in cell cycle-related genes and potentially targetable mutations

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6690095

7 January 2021

Alpha-fetoprotein and p53 autoantibodies in patients with chronic hepatitis C

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6690095

7 January 2021

Use of specific ELISA for the detection of antibodies directed against p53 protein in patients with hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6690095

7 January 2021

Multifactorial analysis of p53 alteration in human cancer: a review

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6690095

7 January 2021

p53 antibodies in the sera of lung cancer patients: comparison with p53 mutation in the tumour tissue

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6690095

7 January 2021

Identifiers

DOI

10.1038/SJ.BJC.6690095

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10027337%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10027337%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

PubMed publication ID

10027337

1 reference